These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38652480)

  • 1. Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents.
    Waqar MA; Zaman M; Khan R; Shafeeq Ur Rahman M; Majeed I
    J Drug Target; 2024 Jul; 32(6):624-634. PubMed ID: 38652480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives in Engineered Mesenchymal Stem/Stromal Cells Based Anti- Cancer Drug Delivery Systems.
    Ackova DG; Kanjevac T; Rimondini L; Bosnakovski D
    Recent Pat Anticancer Drug Discov; 2016; 11(1):98-111. PubMed ID: 26554397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects.
    Gil-Chinchilla JI; Zapata AG; Moraleda JM; García-Bernal D
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
    Layek B; Sadhukha T; Panyam J; Prabha S
    Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment.
    Chulpanova DS; Kitaeva KV; Tazetdinova LG; James V; Rizvanov AA; Solovyeva VV
    Front Pharmacol; 2018; 9():259. PubMed ID: 29615915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration of mesenchymal stem cells to tumor xenograft models and
    Kalimuthu S; Zhu L; Oh JM; Gangadaran P; Lee HW; Baek SH; Rajendran RL; Gopal A; Jeong SY; Lee SW; Lee J; Ahn BC
    Int J Med Sci; 2018; 15(10):1051-1061. PubMed ID: 30013447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells: A living carrier for active tumor-targeted delivery.
    Zhang T; Lin R; Wu H; Jiang X; Gao J
    Adv Drug Deliv Rev; 2022 Jun; 185():114300. PubMed ID: 35447165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles.
    Gao Z; Zhang L; Hu J; Sun Y
    Nanomedicine; 2013 Feb; 9(2):174-84. PubMed ID: 22772046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-edged sword of mesenchymal stem cells: Cancer-promoting versus therapeutic potential.
    Lee HY; Hong IS
    Cancer Sci; 2017 Oct; 108(10):1939-1946. PubMed ID: 28756624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering mesenchymal stem cells: a novel therapeutic approach in breast cancer.
    Heidari R; Gholamian Dehkordi N; Mohseni R; Safaei M
    J Drug Target; 2020; 28(7-8):732-741. PubMed ID: 32463709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal mesenchymal stem cells in cancer therapy.
    Bitsika V; Vlahou A; Roubelakis MG
    Curr Stem Cell Res Ther; 2013 Mar; 8(2):133-43. PubMed ID: 23176305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of mesenchymal stem cells in antineoplastic drugs delivery for tumor-targeted therapy].
    Wang X; Ouyang X; Sun X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):525-533. PubMed ID: 30693696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells in drug/gene delivery: implications for cell therapy.
    Greco SJ; Rameshwar P
    Ther Deliv; 2012 Aug; 3(8):997-1004. PubMed ID: 22946432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal.
    Lee HK; Finniss S; Cazacu S; Bucris E; Ziv-Av A; Xiang C; Bobbitt K; Rempel SA; Hasselbach L; Mikkelsen T; Slavin S; Brodie C
    Oncotarget; 2013 Feb; 4(2):346-61. PubMed ID: 23548312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-Transplantation of Human Umbilical Cord Mesenchymal Stem Cells and Human Neural Stem Cells Improves the Outcome in Rats with Spinal Cord Injury.
    Sun L; Wang F; Chen H; Liu D; Qu T; Li X; Xu D; Liu F; Yin Z; Chen Y
    Cell Transplant; 2019 Jul; 28(7):893-906. PubMed ID: 31012325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
    Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
    BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts.
    Mohr A; Zwacka R
    Cancer Lett; 2018 Feb; 414():239-249. PubMed ID: 29175461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).
    Martin FT; Dwyer RM; Kelly J; Khan S; Murphy JM; Curran C; Miller N; Hennessy E; Dockery P; Barry FP; O'Brien T; Kerin MJ
    Breast Cancer Res Treat; 2010 Nov; 124(2):317-26. PubMed ID: 20087650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle.
    Taheri M; Tehrani HA; Dehghani S; Alibolandi M; Arefian E; Ramezani M
    Med Res Rev; 2024 Jul; 44(4):1596-1661. PubMed ID: 38299924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Tropic Adipose-Derived Mesenchymal Stromal Cell Mediated Bi
    Xiao J; Zeng L; Ding S; Chen Y; Zhang X; Bian XW; Tian G
    Adv Healthc Mater; 2022 Apr; 11(8):e2200143. PubMed ID: 35195958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.